Popular blood pressure medication recalled over efficacy concerns
( NewsNation ) — A pharmaceutical company is voluntarily recalling over 3,700 bottles of blood pressure medication because of efficacy concerns, federal regulators announced last month.
The U.S. Food and Drug Administration said in an enforcement report that the recall applies to 3528 30-count and 216 90-count bottles of Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide Tablets.
Popular organic children's snack recalled over choking risk: FDA
The medication was distributed nationwide between Nov. 21, 2025, and April 27, 2026, and was recalled in October after the Olmesartan Medoxomil failed to meet dissolution testing requirements, according to California's Board of Pharmacy .
Dissolution testing helps assess the quality of a drug by evaluating how well it dissolves and releases its active ingredients when placed in liquid, according to pharmaceutical technology company Pion .
Nearly 6M French press coffee makers recalled after 48 consumers burned
Macleods Pharmaceuticals initiated the recall on Oct. 7 and then designated it a Class II on Oct. 26 , meaning there is a remote probability that using the products will cause serious adverse health consequences.
Copyright 2026 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed. For the latest news, weather, sports, and streaming video, head to NewsNation.
